Lack of epidermal growth factor receptor (EGFR)-activating mutations in triple-negative breast cancer in China

Documenti analoghi

• Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy
  di: Teng, Yvonne Hui-Fang, et al.
  Pubblicazione: (2011)
• Mutations of the Epidermal Growth Factor Receptor Gene in Triple-Negative Breast Cancer
  di: Kim, Aeri, et al.
  Pubblicazione: (2017)
• The role of epidermal growth factor receptor (EGFR) in the efficacy of neoadjuvant chemotherapy in triple-negative breast cancer patients
  di: N. N. Babyshkina, et al.
  Pubblicazione: (2020-04-01)
• Prognostic Evaluation of Epidermal Growth Factor Receptor (EGFR) Genotype and Phenotype Parameters in Triple-negative Breast Cancers
  di: LEVVA, SOFIA, et al.
  Pubblicazione: (2017)
• Triple negative breast carcinoma EGFR amplification is not associated with EGFR, Kras or ALK mutations
  di: Secq, V, et al.
  Pubblicazione: (2014)